Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcomeSANZ, Miguel A; MONTESINOS, Pau; RIVAS, Concha et al.Blood. 2010, Vol 115, Num 25, pp 5137-5146, issn 0006-4971, 10 p.Article

High-Dose Chemotherapy and Immunotherapy in Adult Burkitt Lymphoma : Comparison of Results in Human Immunodeficiency Virus-Infected and Noninfected PatientsORIOL, Albert; RIBERA, Josep-Maria; HOELZER, Dieter et al.Cancer. 2008, Vol 113, Num 1, pp 117-125, issn 0008-543X, 9 p.Article

All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemiaSANZ, Miguel A; VELLENGA, Edo; DE LA SERNA, Javier et al.Blood. 2004, Vol 104, Num 12, pp 3490-3493, issn 0006-4971, 4 p.Article

Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA groupSANZ, Miguel A; MARTIN, Guillermo; DE LA SERNA, Javier et al.Blood. 2004, Vol 103, Num 4, pp 1237-1243, issn 0006-4971, 7 p.Article

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimensMONTESINOS, Pau; RAYON, Chelo; RIVAS, Concha et al.Blood. 2011, Vol 117, Num 6, pp 1799-1805, issn 0006-4971, 7 p.Article

Therapy-Related Myeloid Neoplasms in Patients With Acute Promyelocytic Leukemia Treated With All-Trans-Retinoic Acid and Anthracycline-Based ChemotherapyMONTESINOS, Pau; GONZALEZ, José D; DEBEN, Guillermo et al.Journal of clinical oncology. 2010, Vol 28, Num 24, pp 3872-3879, issn 0732-183X, 8 p.Article

Dose-Intensive Chemotherapy Including Rituximab in Burkitt's Leukemia or Lymphoma Regardless of Human Immunodeficiency Virus Infection Status: Final Results of a Phase 2 Study (Burkimab)RIBERA, Josep-Maria; GARCIA, Olga; GARCIA, Daniel et al.Cancer. 2013, Vol 119, Num 9, pp 1660-1668, issn 0008-543X, 9 p.Article

Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study GroupORIOL, Albert; VIVES, Susana; DEL POTRO, Eloy et al.Haematologica (Roma). 2010, Vol 95, Num 4, pp 589-596, issn 0390-6078, 8 p.Article

Treatment of newly diagnosed acute promyelocytic leukemia (APL) : a comparison of French-Belgian-Swiss and PETHEMA resultsADES, Lionel; SANZ, Miguel A; RAYON, Consuelo et al.Blood. 2008, Vol 111, Num 3, pp 1078-1084, issn 0006-4971, 7 p.Article

Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligandsSANCHEZ-CORREA, Beatriz; MORGADO, Sara; GAYOSO, Inmaculada et al.Cancer immunology and immunotherapy. 2011, Vol 60, Num 8, pp 1195-1205, issn 0340-7004, 11 p.Article

Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in SpainBATLLE, Javier; VILLAR, Ana; CALVENTE, Natividad et al.Blood coagulation & fibrinolysis. 2008, Vol 19, Num 5, pp 333-340, issn 0957-5235, 8 p.Article

Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicinDE LA SERNA, Javier; MONTESINOS, Pau; RIVAS, Concha et al.Blood. 2008, Vol 111, Num 7, pp 3395-3402, issn 0006-4971, 8 p.Article

Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy : long-term outcome of the LPA 99 multicenter study by the PETHEMA GroupSANZ, Miguel A; MONTESINOS, Pau; RIVAS, Concha et al.Blood. 2008, Vol 112, Num 8, pp 3130-3134, issn 0006-4971, 5 p.Article

Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxisMONTESINOS, Pau; DIAZ-MEDIAVILLA, Joaquin; GONZALEZ, José et al.Haematologica (Roma). 2009, Vol 94, Num 9, pp 1242-1249, issn 0390-6078, 8 p.Article

Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy : characteristics, outcome, and prognostic factorsMONTESINOS, Pau; BERGUA, Juan M; RIVAS, Concha et al.Blood. 2009, Vol 113, Num 4, pp 775-783, issn 0006-4971, 9 p.Article

A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma. CommentaryTRICOT, Guido; ROSINOL, Laura; GARCIA-FRADE, Javier et al.Blood. 2008, Vol 112, Num 9, issn 0006-4971, 3532, 3591-3593 [4 p.]Article